Skip to main content

Advertisement

Log in

Roles of Hormones and Signaling Molecules in Describing the Relationship Between Obesity and Colon cancer

  • Review
  • Published:
Pathology & Oncology Research

Abstract

Colon cancer represents a highly prevalent disease in the Western world. While dietary and lifestyle recommendations remain important factors in disease prevention and treatment, epidemiological data have made it clear that obesity and excess body weight remain significant risk factors for the disease. A number of potential direct and indirect relationships exist between obesity and increased risk of colon cancer. Several mechanisms which appear promising and warrant further investigation are discussed here, specifically the modifying role of insulin and insulin-like growth factors, leptin, adipose-tissue induced changes in estrogens and androgens, and inflammatory molecules. A brief review of these hormones and signaling molecules and their action in colon cancer development is described. A thorough integration and understanding of the mechanisms of action these systems exert on colonic epithelia will be important in designing studies and experiments aimed at elucidating disease etiology for prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization official website

  2. National Cancer Institute official website

  3. Jemal A, Murray T, Ward E et al (2005) Cancer Statistics, 2005. CA Cancer J Clin 55:10–30

    Article  PubMed  Google Scholar 

  4. Forte A, De Sanctis R, Leonetti G, Manfredelli S, Urbano V, Bezzi M (2008) Dietary chemoprevention of colorectal cancer. Ann Ital Chir 79:261–267

    PubMed  Google Scholar 

  5. Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147:670–680

    PubMed  CAS  Google Scholar 

  6. Bostick RM, Potter JD, Kushi LH et al (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38–52

    Article  PubMed  CAS  Google Scholar 

  7. Dietz AT, Newcomb PA, Marcus PM, Storer BE (1995) The association of body size and large bowel cancer risk in Wisconsin (United States) women. Cancer Causes Control 6:30–36

    Article  PubMed  CAS  Google Scholar 

  8. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC (1996) Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7:253–263

    Article  PubMed  CAS  Google Scholar 

  9. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA (1997) Leisure-time physical activity, body size, and colon cancer in women. Nurses’ Health Study Research Group. J Natl Cancer Inst 89:948–955

    Article  PubMed  CAS  Google Scholar 

  10. Murphy TK, Calle EE, Rodriguez C, Khan HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152:847–854

    Article  PubMed  CAS  Google Scholar 

  11. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K (1998) β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58:42–46

    PubMed  CAS  Google Scholar 

  12. Yamada Y, Yoshimi N, Hirose Y et al (2000) Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 60:3323–3327

    PubMed  CAS  Google Scholar 

  13. Lee WM, Lu S, Medline A, Archer MC (2001) Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosourea. Cancer Lett 162:155–160

    Article  PubMed  CAS  Google Scholar 

  14. Wargovich MJ, Jimenez A, McKee K et al (2000) Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21:1149–1155

    Article  PubMed  CAS  Google Scholar 

  15. Lanas A, Ferrandez A (2009) NSAIDs and the colon. Curr Opin Gastroenterol 25:44–49

    Article  PubMed  CAS  Google Scholar 

  16. Yang CS, Lambert JD, Ju J, Lu G, Sang S (2007) Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 224:265–273

    Article  PubMed  CAS  Google Scholar 

  17. Holt PR (2008) New insights into calcium, dairy and colon cancer. World J Gastroenterol 14:4429–4433

    Article  PubMed  CAS  Google Scholar 

  18. Franco A, Sikalidis AK, Solís Herruzo JA (2005) Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 97:432–448

    Article  PubMed  CAS  Google Scholar 

  19. Ferguson LR, Philpott M, Karunasinghe N (2004) Dietary cancer and prevention using antimutagens. Toxicology 198:147–159

    Article  PubMed  CAS  Google Scholar 

  20. Bruce WR, Wolever TMS, Giacca A (2000) Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 37:19–26

    Article  PubMed  CAS  Google Scholar 

  21. Giugliano D, Ceriello A, Esposito K (2008) Are there specific treatments for the metabolic syndrome? Am J Clin Nutr 87:8–11

    PubMed  CAS  Google Scholar 

  22. Komninou D, Ayonote A, Richie JP Jr, Rigas B (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228:396–405

    CAS  Google Scholar 

  23. Stipanuk MH (2000) Biochemical and physiological aspects of human nutrition. Saunders, Philadelphia

    Google Scholar 

  24. Kopelman PG (1994) Hormones and obesity. Baillières Clin Endocrinol Metab 8:549–575

    Article  PubMed  CAS  Google Scholar 

  25. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB (2004) The role of inflammation in the pathogenesis of prostate cancer. J Urol 172:S6–11, discussion S11-2

    Article  PubMed  CAS  Google Scholar 

  26. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17:328–336

    Article  PubMed  CAS  Google Scholar 

  27. Sigma Aldrich USA official website

  28. Giovannucci E (2003) Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 35:694–704

    Article  PubMed  CAS  Google Scholar 

  29. Pass C, MacRae VE, Ahmed SF, Farquharson C (2009) Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem Funct 27:119–127

    Article  PubMed  CAS  Google Scholar 

  30. Rajah R, Valentinis B, Cohen P (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181–12188

    Article  PubMed  CAS  Google Scholar 

  31. Rechler MM (1997) Growth inhibition by insulin-like growth factor (IGF) binding protein-3—what’s IGF got to do with it? Endocrinology 138:2645–2647

    Article  PubMed  CAS  Google Scholar 

  32. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34

    PubMed  CAS  Google Scholar 

  33. Björk J, Nilsson J, Hultcrantz R, Johansson C (1993) Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 28:879–884

    Article  PubMed  Google Scholar 

  34. Guo YS, Narayan S, Yallampalli C, Singh P (1992) Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology 102:1101–1108

    PubMed  CAS  Google Scholar 

  35. Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80:51–58

    Article  PubMed  CAS  Google Scholar 

  36. Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M (1987) Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett 38:223–230

    Article  PubMed  CAS  Google Scholar 

  37. Watkins LF, Lewis LR, Levine AE (1990) Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45:372–375

    Article  PubMed  CAS  Google Scholar 

  38. Aaronson SA (1991) Growth factors and cancer. Science 254:1146–1153

    Article  PubMed  CAS  Google Scholar 

  39. Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB (1996) Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 271:29483–29488

    Article  PubMed  CAS  Google Scholar 

  40. Dalgleish AG, O’Byrne K (2006) Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat Res 130:1–38

    Article  PubMed  CAS  Google Scholar 

  41. Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA (2004) Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomark Prev 13:279–284

    Article  CAS  Google Scholar 

  42. Burgering BM, Medema RH, Maassen JA et al (1991) Insulin stimulation of gene expression mediated by p21ras activation. EMBO J 10:1103–1109

    PubMed  CAS  Google Scholar 

  43. Jhun BH, Meinkoth JL, Leitner JW, Draznin B, Olefsky JM (1994) Insulin and insulin-like growth factor-I signal transduction requires p21ras. J Biol Chem 269:5699–5704

    PubMed  CAS  Google Scholar 

  44. Gutierrez L, Magee AI, Marshall CJ, Hancock JF (1989) Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J 8:1093–1098

    PubMed  CAS  Google Scholar 

  45. Goalstone ML, Wall K, Leitner JW et al (1999) Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals. Diabetologia 42:310–316

    Article  PubMed  CAS  Google Scholar 

  46. Leitner JW, Kline T, Carel K, Goalstone M, Draznin B (1997) Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology 138:2211–2214

    Article  PubMed  CAS  Google Scholar 

  47. Ahima RS, Antwi DA (2008) Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am 37:811–823

    Article  PubMed  CAS  Google Scholar 

  48. Jequier E (2002) Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 967:379–388

    Article  PubMed  CAS  Google Scholar 

  49. Stattin P, Lukanova A, Biessy C et al (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer 109:149–152

    Article  PubMed  CAS  Google Scholar 

  50. Jaffe T, Schwartz B (2008) Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123:2543–2556

    Article  PubMed  CAS  Google Scholar 

  51. Tran TT, Medline A, Bruce WR (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomark Prev 5:1013–1015

    CAS  Google Scholar 

  52. Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327–332

    Article  PubMed  CAS  Google Scholar 

  53. Zhu Z, Jiang W, Thompson HJ (2002) An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Mol Carcinog 35:51–56

    Article  PubMed  CAS  Google Scholar 

  54. Attoub S, Noe V, Pirola L et al (2000) Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho-, and Rac-dependent signaling pathways. FASEB J 14:2329–2338

    Article  PubMed  CAS  Google Scholar 

  55. Morton NM, Emilsson V, Liu Y-L, Cawthorne MA (1998) Leptin action in intestinal cells. J Biol Chem 273:26194–26201

    Article  PubMed  CAS  Google Scholar 

  56. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14:75–84

    Article  PubMed  CAS  Google Scholar 

  57. Butler AA, Blakesley VA, Poulaki V, Tsokos M, Wood TL, LeRoith D (1998) Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res 58:3021–3027

    PubMed  CAS  Google Scholar 

  58. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244

    Article  PubMed  CAS  Google Scholar 

  59. Yavari K, Taghikhani M, Ghannadi Maragheh M, Mesbah-Namin SA, Babaei MH (2010) Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells. Int J Colorectal Dis 25:9–16

    Article  PubMed  Google Scholar 

  60. Polderman KH, Gooren LJ, Asscheman H, Bakker A, Heine RJ (1994) Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265–271

    Article  PubMed  CAS  Google Scholar 

  61. Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56:4516–4521

    PubMed  Google Scholar 

  62. Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA (1986) Analysis of pp 60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261:13754–13759

    PubMed  CAS  Google Scholar 

  63. Talamonti MS, Roh MS, Curley SA, Gallick GE (1993) Increase in activity and level of pp 60c-src in progressive stages of human colorectal cancer. J Clin Invest 91:53–60

    Article  PubMed  CAS  Google Scholar 

  64. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE (2002) Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94:344–351

    Article  PubMed  Google Scholar 

  65. Mathew S, George SP, Wang Y et al (2008) Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J Biol Chem 283:22709–22722

    Article  PubMed  CAS  Google Scholar 

  66. Gordon D (1999) Inhibitor of MAP kinase activation blocks colon cancer growth. Gastroenterology 117:523

    Google Scholar 

  67. Park KS, Kim NG, Kim JJ, Kim H, Ahn YH, Choi KY (1999) Differential regulation of MAP kinase cascade in human colorectal tumorigenesis. Br J Cancer 81:1116–1121

    Article  PubMed  CAS  Google Scholar 

  68. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64–S73

    Article  PubMed  CAS  Google Scholar 

  69. Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86:s843–s857

    PubMed  Google Scholar 

  70. Greenberg AS, Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S–465S

    PubMed  CAS  Google Scholar 

  71. Itzkowitz SH, Yio X (2004) Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7–G17

    Article  PubMed  CAS  Google Scholar 

  72. Trayhurn P (2005) Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184:285–293

    Article  PubMed  CAS  Google Scholar 

  73. Paruchuri S, Broom O, Dib K, Sjölander A (2005) The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 280:13538–13544

    Article  PubMed  CAS  Google Scholar 

  74. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866

    Article  PubMed  CAS  Google Scholar 

  75. Lodish H, Darnell J, Matsudaira P, Berk A, Scott MP (2004) Molecular cell biology, 5th edn. W. H. Freeman Company

  76. Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132:3456S–3464S

    PubMed  CAS  Google Scholar 

  77. Furuta Y, Hall ER, Sanduja S, Barkley T Jr, Milas L (1988) Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res 48:3002–7

    PubMed  CAS  Google Scholar 

  78. Martinez ME, Heddens D, Earnest DL et al (1999) Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 91:950–953

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

None

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angelos K. Sikalidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sikalidis, A.K., Varamini, B. Roles of Hormones and Signaling Molecules in Describing the Relationship Between Obesity and Colon cancer. Pathol. Oncol. Res. 17, 785–790 (2011). https://doi.org/10.1007/s12253-010-9352-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-010-9352-9

Keywords

Navigation